EE200000601A - L-karnitiini või alkanoüül-L-karnitiini ning NADH-d ja/või NADPH-d sisaldav kompositsioon - Google Patents

L-karnitiini või alkanoüül-L-karnitiini ning NADH-d ja/või NADPH-d sisaldav kompositsioon

Info

Publication number
EE200000601A
EE200000601A EEP200000601A EEP200000601A EE200000601A EE 200000601 A EE200000601 A EE 200000601A EE P200000601 A EEP200000601 A EE P200000601A EE P200000601 A EEP200000601 A EE P200000601A EE 200000601 A EE200000601 A EE 200000601A
Authority
EE
Estonia
Prior art keywords
carnitine
nadh
nadph
alkanoyl
composition
Prior art date
Application number
EEP200000601A
Other languages
English (en)
Estonian (et)
Inventor
Cavazza Claudio
Original Assignee
Sigma-Tau Healthscience S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.
Publication of EE200000601A publication Critical patent/EE200000601A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200000601A 1998-04-17 1999-04-14 L-karnitiini või alkanoüül-L-karnitiini ning NADH-d ja/või NADPH-d sisaldav kompositsioon EE200000601A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000238A IT1299161B1 (it) 1998-04-17 1998-04-17 Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph
PCT/IT1999/000088 WO1999053921A1 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph

Publications (1)

Publication Number Publication Date
EE200000601A true EE200000601A (et) 2002-04-15

Family

ID=11405812

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000601A EE200000601A (et) 1998-04-17 1999-04-14 L-karnitiini või alkanoüül-L-karnitiini ning NADH-d ja/või NADPH-d sisaldav kompositsioon

Country Status (17)

Country Link
EP (1) EP1071424A1 (sk)
JP (1) JP2002512191A (sk)
KR (1) KR20010042765A (sk)
CN (1) CN1299283A (sk)
AU (1) AU750645B2 (sk)
BR (1) BR9909712A (sk)
CA (1) CA2328331A1 (sk)
EE (1) EE200000601A (sk)
HU (1) HUP0101914A3 (sk)
IL (1) IL139014A0 (sk)
IS (1) IS5663A (sk)
IT (1) IT1299161B1 (sk)
NO (1) NO20005128L (sk)
PL (1) PL343482A1 (sk)
SK (1) SK15442000A3 (sk)
TR (1) TR200002894T2 (sk)
WO (1) WO1999053921A1 (sk)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252309B2 (en) 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
DE10326822A1 (de) * 2003-06-11 2005-01-05 Herzpharma Vita-Check Diagnosegeräte GmbH Mittel zur Nahrungsergänzung, dieses Mittel enthaltende pharmazeutische Präparate und Verwendungen des Mittels
CA2686905C (en) * 2007-05-11 2015-07-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Gel useful for the delivery of cosmetic active ingredients
WO2011022786A1 (en) * 2009-08-31 2011-03-03 Pharmaqest Pty Ltd Methods for diagnosis and treatment of chronic fatigue syndrome
CN104306390A (zh) * 2014-10-23 2015-01-28 苏州人本药业有限公司 还原型辅酶ⅱ的用途
CN104840479A (zh) * 2015-02-17 2015-08-19 苏州人本药业有限公司 Nadph在制备治疗心脏疾病药物中的应用
WO2019119445A1 (zh) * 2017-12-22 2019-06-27 邦泰生物工程(深圳)有限公司 一种nadh复方组合物及其制剂和应用
DK3755160T3 (da) 2018-04-20 2021-12-06 Pacotrade Ag Indretning til findeling af dybfrosne fødevarer, der forefindes i blokform
CN109105702A (zh) * 2018-08-30 2019-01-01 泓博元生命科技（深圳）有限公司 一种含有nadh的组合物、应用及能量补充剂的制备方法
CN109170907A (zh) * 2018-08-30 2019-01-11 泓博元生命科技（深圳）有限公司 一种含有nmn的组合物、应用及运动饮料的制备方法
TWI732309B (zh) * 2018-10-10 2021-07-01 蘇娥 梁 補虛損保健品組合物及其製備方法和其應用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054698A (sk) * 1964-12-04
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
JPH09110708A (ja) * 1995-08-11 1997-04-28 Taisho Pharmaceut Co Ltd 滋養強壮用生薬配合製剤
JPH0959161A (ja) * 1995-08-23 1997-03-04 Taisho Pharmaceut Co Ltd 疲労改善用組成物
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
JPH10175856A (ja) * 1996-10-14 1998-06-30 Taisho Pharmaceut Co Ltd 疲労改善剤

Also Published As

Publication number Publication date
ITRM980238A0 (it) 1998-04-17
HUP0101914A3 (en) 2002-12-28
CN1299283A (zh) 2001-06-13
IT1299161B1 (it) 2000-02-29
AU750645B2 (en) 2002-07-25
IL139014A0 (en) 2001-11-25
EP1071424A1 (en) 2001-01-31
CA2328331A1 (en) 1999-10-28
IS5663A (is) 2000-10-13
JP2002512191A (ja) 2002-04-23
SK15442000A3 (sk) 2001-06-11
ITRM980238A1 (it) 1999-10-17
AU3442899A (en) 1999-11-08
WO1999053921A1 (en) 1999-10-28
BR9909712A (pt) 2000-12-26
TR200002894T2 (tr) 2001-01-22
NO20005128L (no) 2000-12-18
NO20005128D0 (no) 2000-10-12
KR20010042765A (ko) 2001-05-25
PL343482A1 (en) 2001-08-27
HUP0101914A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
HK1024498A1 (en) Adhesive composition and adhesive sheet
IL183948A0 (en) Conjugates of peg-urate oxidase and use thereof
SG85628A1 (en) Compound and its use
AU2052800A (en) Metal and wood bat
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
GB9813271D0 (en) Composition and use
PL347357A1 (en) Novel composition and use
EE200000601A (et) L-karnitiini või alkanoüül-L-karnitiini ning NADH-d ja/või NADPH-d sisaldav kompositsioon
HK1042330A1 (en) Toilet with dual-flushing and method thereof
SG87813A1 (en) Curable epoxide composition and its use
IL136534A0 (en) Magnetic bearing and its use
EP1056455A4 (en) EPIMORPHIN COMPOUND AND USE OF THE SAME
EP1149870A4 (en) COMPOSITION FOR ROLLS AND ROLLS AS MADE
EP1061908A4 (en) COMBINATION THERAPY AND COMPOSITION FOR ACUTE CORONARY MIXING SYNDROME AND ASSOCIATED CONDITIONS
GB9803232D0 (en) Compound composition and use
FI982682A (fi) Uusi komposiitti ja sen käyttö
SG82641A1 (en) Thermal adhesive composition and adhesive sheet thereof
DE69926160D1 (de) Tonerzusammensetzung und deren Herstellung
PL338379A1 (en) Novel photoinitiators and their application
IT1301762B1 (it) Deumidificatore d'aria a struttura semplice e a basso rumore
GB9805172D0 (en) Composition and use
HUP0002529A3 (en) Composition useful for obtaining a matt or dull-glazed coating, use of said composition and resulting coating
EP1111258A4 (en) PAD PROVIDED WITH A FIXING MECHANISM ATTACHED TO THE PAD
FI981702A0 (fi) Puurakennusmenetelmä ja puurakenne
GB9722392D0 (en) Composition and use